187 related articles for article (PubMed ID: 30546831)
1. A combined microfluidic-transcriptomic approach to characterize the extravasation potential of cancer cells.
Bersini S; Miermont A; Pavesi A; Kamm RD; Thiery JP; Moretti M; Adriani G
Oncotarget; 2018 Nov; 9(90):36110-36125. PubMed ID: 30546831
[TBL] [Abstract][Full Text] [Related]
2. PO-12 - The key role of talin-1 in cancer cell extravasation dissected through human vascularized 3D microfluidic model.
Gilardi M; Bersini S; Calleja AB; Kamm RD; Vanoni M; Moretti M
Thromb Res; 2016 Apr; 140 Suppl 1():S180-1. PubMed ID: 27161700
[TBL] [Abstract][Full Text] [Related]
3. Elucidating cancer-vascular paracrine signaling using a human organotypic breast cancer cell extravasation model.
Humayun M; Ayuso JM; Brenneke RA; Virumbrales-Muñoz M; Lugo-Cintrón K; Kerr S; Ponik SM; Beebe DJ
Biomaterials; 2021 Mar; 270():120640. PubMed ID: 33592387
[TBL] [Abstract][Full Text] [Related]
4. A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone.
Bersini S; Jeon JS; Dubini G; Arrigoni C; Chung S; Charest JL; Moretti M; Kamm RD
Biomaterials; 2014 Mar; 35(8):2454-61. PubMed ID: 24388382
[TBL] [Abstract][Full Text] [Related]
5. Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15.
Kelwick R; Wagstaff L; Decock J; Roghi C; Cooley LS; Robinson SD; Arnold H; Gavrilović J; Jaworski DM; Yamamoto K; Nagase H; Seubert B; Krüger A; Edwards DR
Int J Cancer; 2015 Feb; 136(4):E14-26. PubMed ID: 25099234
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the effect of substrate stiffness on the extravasation potential of breast cancer cells using a 3D microfluidic model.
Azadi S; Tafazzoli Shadpour M; Warkiani ME
Biotechnol Bioeng; 2021 Feb; 118(2):823-835. PubMed ID: 33111314
[TBL] [Abstract][Full Text] [Related]
7. A microfluidic model for organ-specific extravasation of circulating tumor cells.
Riahi R; Yang YL; Kim H; Jiang L; Wong PK; Zohar Y
Biomicrofluidics; 2014 Mar; 8(2):024103. PubMed ID: 24803959
[TBL] [Abstract][Full Text] [Related]
8. Lectin Staining of Microvascular Glycocalyx in Microfluidic Cancer Cell Extravasation Assays.
Beyer S; Blocki A; Cheung MCY; Wan ZHY; Mehrjou B; Kamm RD
Life (Basel); 2021 Feb; 11(3):. PubMed ID: 33668945
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic platform for studying osteocyte mechanoregulation of breast cancer bone metastasis.
Mei X; Middleton K; Shim D; Wan Q; Xu L; Ma YV; Devadas D; Walji N; Wang L; Young EWK; You L
Integr Biol (Camb); 2019 Apr; 11(4):119-129. PubMed ID: 31125041
[TBL] [Abstract][Full Text] [Related]
10. ADAMTS-1 Is Found in the Nuclei of Normal and Tumoral Breast Cells.
Silva SV; Lima MA; Cella N; Jaeger RG; Freitas VM
PLoS One; 2016; 11(10):e0165061. PubMed ID: 27764205
[TBL] [Abstract][Full Text] [Related]
11. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation.
Jeon JS; Bersini S; Gilardi M; Dubini G; Charest JL; Moretti M; Kamm RD
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):214-9. PubMed ID: 25524628
[TBL] [Abstract][Full Text] [Related]
12. Adaptable Microfluidic Vessel-on-a-Chip Platform for Investigating Tumor Metastatic Transport in Bloodstream.
Wu Y; Zhou Y; Paul R; Qin X; Islam K; Liu Y
Anal Chem; 2022 Sep; 94(35):12159-12166. PubMed ID: 35998619
[TBL] [Abstract][Full Text] [Related]
13. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
[TBL] [Abstract][Full Text] [Related]
14. A Versatile Microfluidic Platform for Extravasation Studies Based on DNA Origami-Cell Interactions.
García-Chamé M; Wadhwani P; Pfeifer J; Schepers U; Niemeyer CM; Domínguez CM
Angew Chem Int Ed Engl; 2024 Apr; ():e202318805. PubMed ID: 38687094
[TBL] [Abstract][Full Text] [Related]
15. Microfluidic applications on circulating tumor cell isolation and biomimicking of cancer metastasis.
Xu X; Jiang Z; Wang J; Ren Y; Wu A
Electrophoresis; 2020 Jun; 41(10-11):933-951. PubMed ID: 32144938
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo.
Zibara K; Awada Z; Dib L; El-Saghir J; Al-Ghadban S; Ibrik A; El-Zein N; El-Sabban M
Sci Rep; 2015 Jul; 5():12598. PubMed ID: 26218768
[TBL] [Abstract][Full Text] [Related]
17. The cancer glycocalyx mediates intravascular adhesion and extravasation during metastatic dissemination.
Offeddu GS; Hajal C; Foley CR; Wan Z; Ibrahim L; Coughlin MF; Kamm RD
Commun Biol; 2021 Feb; 4(1):255. PubMed ID: 33637851
[TBL] [Abstract][Full Text] [Related]
18. Development of a Single-Cell Migration and Extravasation Platform through Selective Surface Modification.
Roberts SA; Waziri AE; Agrawal N
Anal Chem; 2016 Mar; 88(5):2770-6. PubMed ID: 26833093
[TBL] [Abstract][Full Text] [Related]
19. Probing Intravascular Adhesion and Extravasation of Tumor Cells with Microfluidics.
Osmani N; Follain G; Gensbittel V; García-León MJ; Harlepp S; Goetz JG
Methods Mol Biol; 2021; 2294():111-132. PubMed ID: 33742397
[TBL] [Abstract][Full Text] [Related]
20. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
